In conclusion, our study provides mechanistic and preclinical insight into the critical role of MTA1 in tumor progression and formation of bone metastasis in prostate cancer, at least in part, through the CTSB‐dependent promotion of metastatic pathways (Fig. 6E). This evidence concerns the gene MTA1 and prostate carcinoma.